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Introduction :  Postpartum haemorrhage (PPH) is one of the commonest causes of maternal 
morbidity and mortality. Uterine atony has been showed to be the cause of the most postpartum 
haemorrhage cases. In 2009 World Health Organization (WHO) in booklet for Prevention of Postpartum 
Haemorrhage has highly recommended active management of third stage of labour in attempt to reduce 
the incidence of postpartum haemorrhage by using uterotonic agents like oxytocin or carbetocin as 
part of active management of third stage of labour is highly recommended to prevent post partum 
haemorhhage. These medications can affect haemodynamic parameters including reduce in 
blood pressure and increase in heart rate. Carbetocin is an uterotonic agents licensed to be used 
in Malaysian Health Ministry since 2011.   
` 
 
Objective:  The aim of this study were to compare the haemodynamic changes of carbetocin 
versus oxytocin on maternal hemodynamic parameters during caesarean section. This study also 
evaluate the side effects profile of both research drugs including comparing estimated blood loss 
during caesarean delivery when using either oxytocin or carbetocin. 
 
Patients and Method:  This is a prospective, randomized double blind study. There were 
one hundred twenty patients undergoing elective or emergency lower segment caesarean section 
under spinal anaesthesia. There were randomized to receive either IV oxytocin 5 IU or IV 
carbetocin 100 µg after delivery of baby. Vasopressor such as ephedrine or phenylephrine were 
advocated to maintain blood pressure at least around 15% of baseline before research drug is 
given. We compare the haemodynamic parameters such SBP, DBP, MAP and HR. The side 
effects profile also has been compared including the need of additional uterotonic agents 
 
Results:  It has been observed that there were reduction in systolic and diastolic blood 
pressure after both drugs are given however there were no statistically significant value between 
both drug’s group (p > 0.05).  Mean arterial pressure as well as heart rate also affected but the 
difference was not statistically significant. Estimated blood loss in group carbetocin were less 
(410.6 ± 142.3) and statistically significant when compared to group oxytocin (433.8 ± 258.4),   
p < 0.05.  This study revealed that there were no significant differences in term of uterine tone 
score, side effects profile and need for additional uterotonics agents. 
  
 
` 
 
 
Conclusion :  We conclude that there were rapid onset and offset of undesirable 
haemodynamic effects of either oxytocin 5 IU or carbetocin and the difference between oxytocin 
5 IU and 100 µg carbetocin were minor and statistically not significant. The side effects profiles 
of both drugs are similar and not significant while it is proven that usage of carbetocin cause less 
blood loss compared to oxytocin. There were no significant values in usage of additional 
uterotonic agents between group oxytocin and carbetocin. 
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CHAPTER 1   INTRODUCTION 
 
Postpartum haemorrhage (PPH) is one of the commonest causes of maternal morbidity 
and mortality. Massive bleeding in PPH can be detrimental and affect the outcome of 
parturient. Uterine atony has been showed to be the cause of the most postpartum 
haemorrhage cases. In 2009 World Health Organization (WHO) in booklet for Prevention 
of Postpartum Haemorrhage has highly recommended active management of third stage 
of labour in attempt to reduce the incidence of postpartum haemorrhage. Therefore the 
usage of uterotonic drugs during Caesarean delivery has become essential to diminish the 
risk of PPH. Currently available uterotonic drug licensed to be use in Malaysia includes 
pitocin, syntocinon, syntometrine, carboporost and recently introduced is carbetocin.  
 
Practice varies widely in the administration of oxytocin at Caesarean delivery. The 
British National Formulary presently recommends that oxytocin should be administered 
in a 5 IU dose by slow intravenous injection after delivery during Caesarean section 
(Formulary 2001). Currently in most maternity center in Malaysia, IV Oxytocin 5 IU is 
recommended as the prophylactic medication of choice to prevent uterine agony as this 
therefore will reduce the incidence of postpartum haemorrhage during Caesarean section. 
Oxytocin has a short half-life. Oxytocin is given bolus after delivery of baby and it need 
to be given as infusion for over 6 hours post bolus dose.  
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The haemodynamic effects of an oxytocin bolus consist of systemic vasodilatation, with 
hypotension, tachycardia, and an increase in cardiac output and pulmonary artery 
pressure, resulting in brief hypotension and tachycardia in a dose-dependent manner. 
oxytocin, given by rapid intravenous bolus, has the potential to cause dangerous 
haemodynamic collapse in women unable to mount compensatory increases in cardiac 
output such as those with hypovolemia and cardiac disease (Pinder et al., 2002). Apart 
from that, large doses are also associated with nausea, vomiting, dysarrthymia, ST 
segment changes, pulmonary edema and severe water intoxication (Moran et al., 2001). 
 
Recently new uterotonic drug namely carbetocin has been introduced to Malaysian 
Health Ministry hospitals in second half year 2011. Duratocin® (carbetocin injection) is a 
long-acting synthetic octapeptide analogue of oxytocin with agonist properties. It can be 
administered intravenously as a single dose immediately following delivery by Caesarean 
section under epidural or spinal anaesthesia, to prevent uterine atony and postpartum 
haemorrhage. The clinical and pharmacological properties of carbetocin are similar to 
those of naturally occurring oxytocin, another posterior pituitary hormone. In vitro 
studies, carbetocin was shown to bind to the oxytocin receptor with similar affinity as the 
natural peptide. Carbetocin elicited similar uteronic and galactogogic effects to oxytocin 
in animals and in vitro. Carbetocin was less potent than oxytocin, but its action was more 
prolonged up to 4-6 hours therefore carbetocin is only given bolus and no infusion 
needed. Study by Jetya et al showed that by using carbetocin, the usage of additional 
uterotonic agent is decreased. Although carbetocin cost more but looking at overall cost 
effectiveness, carbetocin is a drug of choice. 
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In one of the pilot study, Moertl et al in haemodynamic effects of carbetocin and 
oxytocin given as intravenous used non invasive monitoring that includes 
electrocardiography, ICG , beat to beat blood pressure by the vascular unloading were 
used to look in detail the haemodynamic effects of these two uterotonics drugs. Both 
oxytocin and carbetocin have comparable haemodynamic effects and are uterotonic drugs 
with an acceptable safety profile for prophylactic use. Minimal differences in the 
recovery phase beyond 70 seconds are in keeping with the fact that carbetocin has an 
extended half-life compared with oxytocin.  
 
In Maternity Operation Theatre Hospital Sultanah Bahiyah, patient will be labeled as low 
risk group or high risk group developing PPH . Low risk group such as primigravida, 
with no significant obstetrical history will be given IV oxytocin 5 IU slow bolus followed 
by IV oxytocin 40 IU infusion over 6 hours. On the other hand if parturient are in the 
high risk group such as grandmutipara, prolonged labour, macrosomic baby, elderly 
primigravida, placenta praevia, twin gestation, IV carbetocin 100 µg will be given 
prophylactically. However if patient developed postpartum haemorrhage (PPH) that is 
when blood loss is more than 1000 ml or uterine contraction is unsatisfactory, 
Intramuscular carboprost 250 µg will be advocated. Expectant management of 
postpartum haemorrhage will be practiced accordingly by both anaesthestist & surgeon. 
 
Pregnancy involved various changes since first trimester until third trimester. At term, 
cardiac output is 33% higher than normal with marked decrease in supine position owing 
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to obstruction of the inferior vena cave. This contributed by 15% increase in heart rate 
and 35% increase in stroke volume. As much as 20% of the cardiac output goes to uterus 
(800ml/min) (Sinclair 1963). Because of the cardiovascular changes associated with 
pregnancy and spinal anaesthesia, the use the drugs especially those which causes 
hypotension and tachycardia must be done cautiously during delivery and Caesarean 
section. 
 
Lower segment Caesarean section has gained its popularity over last three decades. 
Caesarean delivery is preferred in situation where vaginal delivery is not feasible. The 
anaesthetic technique for Caesarean delivery can be either by giving general anaesthesia 
or regional anaesthesia. Regional anesthesia either by giving epidural or single shot 
subarachnoid block is preferred since its associated with less risk of failed intubation 
neither it will contribute to the increased risk of bleeding . However both regional 
anaesthesia techniques can cause hypotension secondary to loss of vasomotor tone. 
Various studies has been done to look on how to reduce the incidence of hypotension by 
adjusting the local anaesthetic dose, fluid preloading, type of fluid given and also choice 
of vasopressor was also taken into account. 
 
The purpose of this study was to compare the haemodynamic profile including SBP, 
DBP, HR and MAP as well as side effects of oxytocin and carbetocin given during 
Caesarean delivery. There are many study done looking into the effectiveness if 
carbetocin in term of contractility of uterus and the ability to reduce incidence of PPH , 
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however the haemodynamic analysis for this drug is lacking particularly in Asian 
population. 
 
CHAPTER 2  LITERATURE REVIEW 
 
2.1 PHYSIOLOGICAL CHANGES DURING PREGNANCY 
The physiological adaptation to pregnancy causes significant changes in the 
cardiovascular system to allow the women to manage the increased metabolic 
requirements of the growing fetus. Whilst women with normal cardiac structure and 
function can adapt well, women with cardiac disease may decompensate which can lead 
to complications in pregnancy and even result in fetal and maternal death. The increase in 
work required by the heart is due to growing fetus with increasing oxygen consumption, 
enlarging uterus and breasts requiring greater oxygen demand, increase in work by 
mother due to 10–14 kg weight gain, placental bed acting like an arterio-venous fistula. 
 
The physiological changes affect preload, intrinsic cardiac contraction, and the afterload. 
Cardiac preload is increased due to the increase in circulating volume which occurs from 
6 weeks gestation and plateaus by the end of the second trimester at a level 50–70 % 
above the non-pregnant state. Red cell mass also increases but only by 40 % thus there is 
greater proportional increase in volume compared to red cell mass, leading to a relative 
haemodilution, the so called physiological anaemia of pregnancy. As a result of this 
blood volume increase, left ventricular end-diastolic (LVED) volume is increased which 
can be noticed on echocardiogram from 10 weeks’ gestation. There is also a 
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corresponding increase in atrial and right ventricular chamber dimensions. This increase 
in blood volume creates particular problems for women with dilated cardiomyopathy and 
obstructive outflow lesions such as mitral stenosis or pulmonary hypertension. 
 
Systemic vascular resistance (SVR) is the resistance of all the peripheral vasculature in 
the systemic circulation, and this should not be confused with pulmonary vascular 
resistance (PVR), which is the resistance only in the pulmonary circulation. SVR is 
measured by looking at the change in pressure across the systemic circulation from 
beginning to end and dividing it by the cardiac output. The afterload is the force against 
which the cardiac muscle has to contract and typically is reduced in pregnancy due to the 
fall in SVR. This reduction in resistance occurs from the 5th week of pregnancy and 
usually reaches its nadir between 20 and 32 weeks of gestation. After 32 weeks, the SVR 
rises again until term by which it has exceeded its pregnancy level. 
 
The reduction in SVR is due to a combination of increased circulating vasodilators, 
namely prostacyclin (PGI2) and to the diversion of blood into the low impedance 
uteroplacental circulation. There is significant increase in blood flow in the early stages 
of pregnancy; however, this is countered by a decrease in PVR, resulting in no net 
changes in pulmonary artery pressure. 
 
The reduction in SVR results in increased flow to different anatomical beds and resulting 
physiological changes. Renal blood flow increases to 60–80 % above pre-pregnancy 
levels and peaks in the third trimester. This change coincides with a 50 % increase in 
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glomerular filtration rate (GFR), which is why normal blood levels of creatinine in 
pregnancy are reduced common in pregnancy. 
 
Stroke volume is the volume of blood from the ventricle with each beat and is 
approximately 70mls in a healthy adult male. It is a major determinant of cardiac output 
(CO) as CO is the product of stroke volume and heart rate (HR), both of which are 
increased during pregnancy. CO increases by approximately 30–50 % reaching a peak at 
the end of the second trimester. The majority of CO increase is as a result of increase in 
stroke volume, though HR does contribute. HR is particularly important at the end of 
pregnancy, as the increase in stroke volume plateaus however the HR continues to rise. 
Women with fixed COs in the form of stenotic valve lesions are at risk of maternal and 
fetal compromise. 
 
The increase in HR peaks in the late second or early third trimester and is usually 10–20 
beats above pre-pregnancy levels, although there is a wide variation, and it is not 
uncommon to see women towards the end of their pregnancy with a sinus tachycardia. 
Maternal peak oxygen consumption can increase by 20–30 % at term as a result of both 
the increase in maternal and fetal tissue mass as well as the increase in cardiac and 
respiratory work. The increase in myocardial oxygen consumption may therefore trigger 
ischaemia in women with significant coronary disease. 
 
Venous distension increases approximately to 150% during the course of gestation and 
the venous ends of capillaries become dilated, causing reduced blood flow. These 
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vascular changes contribute to delayed absorption of subcutaneously or intramuscularly 
injected substances. Distension of the extradural veins heightens the risk of vascular 
damage during institution of a regional block. The increased venous volume within the 
rigid spinal canal reduces the volume or capacity of the extradural and intrathecal spaces 
for local anaesthetics solutions. This will increase the cephalad spread of the injected 
drugs (Sinclair 1963). 
 
Figure 2.1 Changes of plasma volume, heart rate, stroke volume and cardiac output 
during pregnancy 
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Table 2.1 Summary of changes during pregnancy simplified using arrow 
 
 Changes at Various Times (week) 
Parameter 5 12 20 24 32 38 
Heart rate 
 
      
Systolic blood 
pressure 
      
Diastolic 
blood pressure 
      
Stroke volume 
 
      
Cardiac 
Output 
 
      
Systemic 
vascular 
resistance 
      
Left 
ventricular 
ejection 
fraction 
      
 
From : Langesaeter E, Dragsund M, Rosseland La.(2010) Regional anaesthesia for a 
Caesarean section in women with cardiac disease: a prospective study. Acta Anaesthesiol 
Scand. 2010 Jan;54(1):46-54. 
 
In summary, parturient experienced tremendous physiological changes including 
hormonal and effect psychological aspect as well. Furthermore there will more 
cardiocirculatory changes will occur during labour and delivery. As an anaesthetist, 
meticulous care should be taken together with obstetric team during managing this unique 
group of patients.  
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2.2 PHYSIOLOGICAL CHANGES DURING LABOUR AND DELIVERY 
 
Pregnancy is state where there are changes involving almost all system in the body. 
These changes happen gradually within 37 weeks of pregnancy. During labour parturient 
experienced series of changes in order both mother and fetus to adapt condition during 
expulsion of fetus. This is a unique process involving several transient cardiocirculatory 
changes 
2.2.1 Effect on cardiac output 
CO increases up to 30% in the first stage of labour primarily because of increased stroke 
volume. Maternal pushing efforts in the second stage of labour can increase CO by as 
much as 50%. Compression of the uterus with contractions results in an increase in 
circulating blood volume and venous return to the heart, with concomitant increase in 
stroke volume. Pulmonary arterial venous oxygen difference also increases with 
contractions, addition of flow of blood from the maternal uterine vascular bed into the 
systemic circulation. Pain and anxiety leads to increased sympathetic tone with increased 
blood pressure and heart rate, which also contributes to the increased cardiac output. 
2.2.2 Effects on Maternal Heart Rate 
In contrast with cardiac output, the effects of contractions on maternal heart rate seem to 
be more variable. The observed differences in reported heart rate responses to uterine 
contractions relate to differences in maternal position and pain control during labour, as 
well as individual variation. 
 
 
   21  
 
 
2.2.3 Effects on Maternal blood pressure 
Both systolic and diastolic blood pressure increase with uterine contractions and this 
increase seem to precede a contraction by up to 8 seconds. The maximal increase occurs 
in the second stage of labour. Because peripheral resistance changes only slightly during 
labour, the increase in blood pressure is attributed to increased cardiac output. As 
expected, the hemodynamic effects of uterine contractions are less pronounced in the left 
lateral recumbent position. Oxygen consumption increases about 3-fold during uterine 
contractions, with its mean value increasing gradually to levels 100% higher than those 
before labour. 
2.2.4 Effects of Maternal Anesthesia 
Uterine contraction will cause tachycardia during second stage of labour and it can be 
additive due to pain during contraction and this can occur if local anaesthesia is 
inadequate. Both the systolic and diastolic blood pressure shows a mild gradual increase 
during the first stage of labour and a significant increase during the second stage. These 
changes are associated with a progressive increase in stroke volume toward a peak 
immediately following delivery. In contrast, regional anesthesia however can obtund the 
extreme changes of blood pressure and heart rate during first and second stage of labour. 
Many patients with regional anaesthesia have transient hypotension early on, which can 
be mitigated with pre induction volume load. On the other hand, stroke volume in patient 
under regional anaesthesia remains constant throughout labour but increases rapidly after 
delivery. Mean blood loss does not seem to be affected by type of anaesthesia at delivery. 
In patients with underlying cardiac disease, anaesthesia during labour and delivery can 
pose unique challenges. Continuous lumbar epidural anaesthesia with or without 
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narcotics, is frequently optimal. Limited sympathetic blockade and its effects on preload 
and afterload can be helpful in patients with mitral valve lesions. In patients with more 
complex lesions, anesthesia options must be considered on a case-by-case basis using a 
multidisciplinary approach. 
2.2.5 Haemodynamic effects during Caesarean delivery 
Transient maternal hypotension can occur in up to 30% of women undergoing regional 
anaesthesia for Caesarean section, but most women undergoing Caesarean section under 
epidural anaesthesia remain stable haemodynamically. Blood pressure typically declines 
moderately after anaesthesia induction, but then remains constant throughout operation. 
In addition, heart rate and stroke volume remain constant. Following delivery, cardiac 
output increases about 25% more than baseline, with a stable HR. In contrast, Caesarean 
section under spinal anaesthesia is associated with significant cardiovascular changes and 
should be used with extreme caution in patients with heart disease. Hemodynamic 
fluctuations during Caesarean section were less with thiopental, nitrous oxide, and 
succinylcholine anaesthesia. Thus, balanced anaesthesia with thiopental, nitrous oxide, 
and succinylcholine, or epidural anaesthesia without epinephrine, are preferred in patients 
with limited cardiac reserves. 
After delivery of baby, mother’s haemodynamic changes once again challenged due to 
administration of uterotonic agent. These agents such as oxytocin, carbetocin, 
ergometrine or prostaglandin can cause transient tachycardia and hypotension secondary 
to vasodilatation. These changes will be explained in detail in next topic. 
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2.3 HEMODYNAMIC CHANGES DURING POSTPARTUM PERIOD 
 
There will be 60% to 80% increase in cardiac output occurs immediately after delivery, 
followed by a rapid decrease within 10 minutes to values approaching normal within 1 
hour postpartum. In addition, systemic vascular resistance decreases. This high output 
state is likely caused by the transfer of blood from the uterus into the systemic circulation 
(autotransfusion) in conjunction with improved venous return caused by decreased vena 
caval compression and the rapid mobilization of extracellular fluid. Placental separation 
in the third stage of labour does not cause any further hemodynamic changes. Even 
though childbirth can result in a mean blood loss of 1000 ml or more, patients are 
protected by the significant blood volume expansion during pregnancy. In women with 
postpartum haemorrhage, compensatory effect stroke volume decreases and heart rate 
increases, whereas blood pressure and cardiac output remained stable. Equally important, 
levels of atrial natriutic peptide increase durring postpartum. Atrial natriutic peptide have 
potent diuretic effects, and help mediate the diuresis noted in the early postpartum period. 
Summary of changes during postpartum period is shown below. 
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Table 2.2 Cardiovascular changes during pregnancy, peripartum, and postpartum     
 
 Pregnancy Peripartum Postpartum 
Blood volume    
Systolic blood 
pressure 
   
Diastolic blood 
pressure 
   
Systemic vascular 
resistance 
   
Heart rate    
Stroke volume    
Cardiac output    
 
From: Sinclair J.D (1963) Cardiovascular changes during pregnancy.Mod Trends Hum 
Repro Physiol,15, 175-89.  
 
 
 
 
 
